Skip to content

Author

D. Dahiya

We have 5 of 502 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical outcomes associated with GLP-1 receptor agonist use in metabolic dysfunction–associated steatohepatitis

Metabolic dysfunction–associated steatohepatitis (MASH) is an important progressive liver disorder that can lead to hepatic decompensation, hepatocellular carcinoma (HCC), and premature death. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated beneficial effects on metabolic dysfunction and liver h...

S. Khan, Anuj Subedi, Anurag Marasini et al. · 0 citations
Open access Sep 2026

Burden of Pancreatitis in the United States from 1990 to 2023: Findings from the Global Burden of Disease Study 2023

Objectives: Pancreatitis is the third leading cause of gastrointestinal disease-related hospitalization. Pancreatitis burden has continued to increase since 1990, with trends driven by changing exposures to risk factors, population growth, and population aging. We report the national- and state-level estimates of pancr...

M. M. Reddy, Anish Chopra, G. Aswath et al. · 0 citations
Open access Sep 2026

Deaths Mentioning Both Pancreatic Cancer and Renal Failure in the United States, 1999–2024: Temporal Trends and Disparities

Background: We examined temporal trends in deaths mentioning both pancreatic cancer and renal failure in the United States. Methods: We analyzed CDC WONDER multiple-cause-of-death data for adults aged ≥25 years from 1999 to 2024. Age-adjusted mortality rates (AAMRs) were assessed using Joinpoint regression. Secondary a...

A. Dhali, Ali Shan Hafeez, J. Biswas et al. · 0 citations
Review Open access Sep 2026

Safety and Efficiency of Robotic Versus Laparoscopic Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis

Findings should be interpreted as hypothesis-generating rather than definitive evidence of superiority or equivalence, but larger, prospective, multi-centre studies with standardised outcome definitions and robust adjustment for confounding are needed to clarify the comparative clinical and cost-effectiveness of roboti...

H. Bharadwaj, E. Danda, S. H. Ali et al. · 0 citations
Review Open access Aug 2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023–2026 evidence and a proposed clinical integration framework

A narrative review synthesizes evidence published between 2020 and 2026 within a unified clinical framework not provided by prior reviews, and proposes an original biomarker-guided clinical algorithm, a comparative clinical readiness table, and a disease-continuum biomarker timeline as practical tools for clinicians an...

Ashish Sharma, J. Tan, Rajvardhan Sisodia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.